Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review ERCC8 (excision repair cross-complementing rodent repair deficiency, complementation group 8) Anne Stary, Alain Sarasin Laboratory of Genetic Instability and Cancer, UPR2169 CNRS, Institut de Recherches sur le Cancer, 7, rue guy Moquet, BP 8, 94801 Villejuif, France (AS, AS) Published in Atlas Database: September 2001 Online updated version : http://AtlasGeneticsOncology.org/Genes/CSAID301.html DOI: 10.4267/2042/37805 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2002 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Protein Other names: CSA (Cockayne syndrome A); CKN1; ERCC8 HGNC (Hugo): ERCC8 Location: 5q12.1 Description 396 amino acids - 44 kDa. Function The Cockayne syndrome group A (CSA) gene encodes a WD repeat protein that interacts with the Cockayne syndrome group B (CSB) protein and a subunit of RNA polymerase II transcription factor TFIIH suggesting that the products of CSA and CSB genes are involved in transcription. The CSA defect leads to defective strand specific repair of transcriptionally active genes. Mutations Germinal One base substitution. Implicated in Cockayne syndrome, CS group A Note: See also the paper on Nucleotide Excision Repair. Disease The Cockayne syndrome A is characterized by sensitivity to sunlight, dwarfism, precociously senile appearance, pigmentary retinal degeneration, optic atrophy and deafness. DNA/RNA References Transcription Cleaver JE, Volpe JP, Charles WC, Thomas GH. Prenatal diagnosis of xeroderma pigmentosum and Cockayne syndrome. Prenat Diagn. 1994 Oct;14(10):921-8 CSA (5) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics. 2011 b. Atlas Genet Cytogenet Oncol Haematol. 2002; 6(1) 11 ERCC8 (excision repair cross-complementing rodent repair deficiency, complementation group 8) Henning KA, Li L, Iyer N, McDaniel LD, Reagan MS, Legerski R, Schultz RA, Stefanini M, Lehmann AR, Mayne LV, Friedberg EC. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell. 1995 Aug 25;82(4):555-64 monoallelic mutation analysis in somatic cell hybrids. Hum Mutat. 1997;10(4):317-21 Sarasin A, Stary A. Human cancer and DNA repair-deficient diseases. Cancer Detect Prev. 1997;21(5):406-11 Tu Y, Bates S, Pfeifer GP. The transcription-repair coupling factor CSA is required for efficient repair only during the elongation stages of RNA polymerase II transcription. Mutat Res. 1998 May 25;400(1-2):143-51 Bregman DB, Halaban R, van Gool AJ, Henning KA, Friedberg EC, Warren SL. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11586-90 Conforti G, Nardo T, D'Incalci M, Stefanini M. Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation. Oncogene. 2000 May 18;19(22):271420 Itoh T, Shiomi T, Shiomi N, Harada Y, Wakasugi M, Matsunaga T, Nikaido O, Friedberg EC, Yamaizumi M. Rodent complementation group 8 (ERCC8) corresponds to Cockayne syndrome complementation group A. Mutat Res. 1996 Feb 15;362(2):167-74 Hanawalt PC. DNA repair. The bases for Cockayne syndrome. Nature. 2000 May 25;405(6785):415-6 Ozdirim E, Topçu M, Ozön A, Cila A. Cockayne syndrome: review of 25 cases. Pediatr Neurol. 1996 Nov;15(4):312-6 Khan GQ, Hassan G, Yaseen M, Masood T, Hajini GH, Akhtar D, Qureshi T. Cockayne syndrome. J Assoc Physicians India. 2000 Nov;48(11):1119-21 Stefanini M, Fawcett H, Botta E, Nardo T, Lehmann AR. Genetic analysis of twenty-two patients with Cockayne syndrome. Hum Genet. 1996 Apr;97(4):418-23 Luo Z, Zheng J, Lu Y, Bregman DB. Ultraviolet radiation alters the phosphorylation of RNA polymerase II large subunit and accelerates its proteasome-dependent degradation. Mutat Res. 2001 Sep 4;486(4):259-74 van Oosterwijk MF, Versteeg A, Filon R, van Zeeland AA, Mullenders LH. The sensitivity of Cockayne's syndrome cells to DNA-damaging agents is not due to defective transcriptioncoupled repair of active genes. Mol Cell Biol. 1996 Aug;16(8):4436-44 McKay BC, Chen F, Clarke ST, Wiggin HE, Harley LM, Ljungman M. UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 or MLH1. Mutat Res. 2001 Mar 7;485(2):93-105 Dianov GL, Houle JF, Iyer N, Bohr VA, Friedberg EC. Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells. Nucleic Acids Res. 1997 Sep 15;25(18):3636-42 This article should be referenced as such: Stary A, Sarasin A. ERCC8 (excision repair crosscomplementing rodent repair deficiency, complementation group 8). Atlas Genet Cytogenet Oncol Haematol. 2002; 6(1):11-12. McDaniel LD, Legerski R, Lehmann AR, Friedberg EC, Schultz RA. Confirmation of homozygosity for a single nucleotide substitution mutation in a Cockayne syndrome patient using Atlas Genet Cytogenet Oncol Haematol. 2002; 6(1) Stary A, Sarasin A 12